Author: Emily Adamek (Change) Medical Reviewer: Kristen Fuller, MD (No change) Primary Changes: Fact-checked and edited for readability
The medication is an experimental medication produced by Eli Lilly
It is indicated for the treatment of adult patients with the following conditions: Metastatic colorectal cancer who have received prior treatment with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF biological therapy, and if they have RAS wild-type, an anti-EGFR therapy
This may include prescription weight loss medications like Compounded Semaglutide, Oral Semaglutide, Ozempic, Compounded Tirzepatide, Oral Tirzepatide, Mounjaro, Zepbound, or Wegovy, depending on your eligibility and needs